Wells Fargo’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-314
| Closed | -$55 | – | 7446 |
|
|
2022
Q4 | $55 | Buy |
314
+8
| +3% | +$1 | ﹤0.01% | 6655 |
|
|
2022
Q3 | $0 | Buy |
306
+28
| +10% | – | ﹤0.01% | 7455 |
|
|
2022
Q2 | $0 | Sell |
278
-43,615
| -99% | – | ﹤0.01% | 7524 |
|
|
2022
Q1 | $242K | Sell |
43,893
-13,888
| -24% | -$76.6K | ﹤0.01% | 4580 |
|
|
2021
Q4 | $559K | Buy |
57,781
+10,300
| +22% | +$99.6K | ﹤0.01% | 4281 |
|
|
2021
Q3 | $848K | Buy |
47,481
+2,207
| +5% | +$39.4K | ﹤0.01% | 4109 |
|
|
2021
Q2 | $1.11M | Buy |
45,274
+37,905
| +514% | +$925K | ﹤0.01% | 3922 |
|
|
2021
Q1 | $195K | Sell |
7,369
-24,028
| -77% | -$636K | ﹤0.01% | 4845 |
|
|
2020
Q4 | $238K | Buy |
31,397
+12,894
| +70% | +$97.7K | ﹤0.01% | 4867 |
|
|
2020
Q3 | $93K | Sell |
18,503
-57
| -0.3% | -$286 | ﹤0.01% | 5098 |
|
|
2020
Q2 | $111K | Sell |
18,560
-469
| -2% | -$2.81K | ﹤0.01% | 4973 |
|
|
2020
Q1 | $84K | Sell |
19,029
-323
| -2% | -$1.43K | ﹤0.01% | 4946 |
|
|
2019
Q4 | $184K | Sell |
19,352
-1,150
| -6% | -$10.9K | ﹤0.01% | 4843 |
|
|
2019
Q3 | $161K | Buy |
20,502
+1,180
| +6% | +$9.27K | ﹤0.01% | 4887 |
|
|
2019
Q2 | $305K | Sell |
19,322
-1,854
| -9% | -$29.3K | ﹤0.01% | 4570 |
|
|
2019
Q1 | $383K | Buy |
21,176
+15,141
| +251% | +$274K | ﹤0.01% | 4424 |
|
|
2018
Q4 | $97K | Buy |
6,035
+2,614
| +76% | +$42K | ﹤0.01% | 5056 |
|
|
2018
Q3 | $82K | Buy |
+3,421
| New | +$82K | ﹤0.01% | 5178 |
|